Details of the Drug Reposition | DrugMAP

General Information of This Drug (ID: DMR69CG)

Drug Name	XEN-402 DMR69CG
Drug Type	Small molecular drug
Structure
Structure	3D MOL			2D MOL

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)

3 Phase 2 Indication(s)

Indication Name	Indication ID	ICD-11	Status	REF
Vasodilatation of extremities	DISDPT21	EG00	Phase 2	[1]
Osteoarthritis	DIS05URM	FA00-FA05	Phase 2	[2]
Pain	DIS4RWOW	MG30-MG3Z	Phase 2	[3]
------------------------------------------------------------------------------------

References

1	Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
2	ClinicalTrials.gov (NCT02068599) A Study to Evaluate the Safety and Efficacy of Topically Applied TV-45070 Ointment) in Participants With Primary Osteoarthritis (OA) Affecting a Single Knee. U.S. National Institutes of Health.
3	ClinicalTrials.gov (NCT01195636) A Crossover Study to Evaluate the Safety, Tolerability and Efficacy of XPF-002 in Subjects With Postherpetic Neuralgia (PHN). U.S. National Institutes of Health.